EFTA00235926.pdf

Wealth Ghislaine Maxwell Management Investment Proposal February-14 Prepared by: Stackman I Casriel Group UBS Financial Services Scott Stackman Lyle Casriel Matthew Klein, CFA Managing Director Senior Vice President Financial Advisor Private Wealth Management Private Wealth Management Private Wealth Management CONFIDENTIAL UBSTERRAMAR00000197 EFTA00235926  Ghislaine Maxwell sUBS Wealth Management Asset Allocation Summary February -)4 Current Proposed LIQUID ALTERNATIVE INVESTMENTS 18% FIXED INDOME 37% CASH & EOUNALENTS CASH 43% EQUIVALENTS 16% EQUITY 29% Current UBSA Proposed Current Proposed Reallocation (%) (%) Amount Amount EQUITY USEquity 19.3% 21.0% 17 $ 2,702,536 $ 2,500,000 (202,536) International Equity 14.5% 13.5% 10.7% $ 2,032,507 1,500,000 5 (532,507) 'Equity Subtotal 33.8% 34.5% 28.5% S 4,735,043 $ 4,000,000 (735,043) FIXED INCOME MunicipalFixedIncome 1.5% 26.5% 12.2% 215.376 S 1,715,376 1,500.000 Taxable US fixedIncome 20.8% 8.0% 21.8% 2,921,863 $ 3,056,821 134,958 InternationalFixedIncome 0.7% 3.0% 3.6% 94,939 $ 500,000 405,061 'FixedIncome Subtotal 23.1% 37.5% 37.6% S 3,232,178 $ 5,272,197 S 2.040.019 ALTERNATIVE INVESTMENTS MutualFundLiquid Alternatives 0.2% 14.0% 17 8% 31,576 2,500,000 2,468,424 Private Equity/ Private RealEstate 0.0% 12.0% 0 0% S Commodities /HardAssets 0.2% 2.0% 00% 22,062 $ (22,062) 'AlternativeInvestments Subtotal 0.4% 28.0% 17.8% S 53,638 S 2,500,000 $ 2.446,362 CASH & EQUIVALENTS Cash, Money Markets, and Cash Alternatives 42.8% 0.0% 16.0% $ 5,997,302 2,245,964 $ (3,751,338) Cash/Cash Equivalents Subtotal 42.8% 0.0% 16.0% S 5,997,302 $ 2,245,964 S (3,751,338) TOTAL 100% 100% 100% 14,018,161 S 14,018,161 S AUBS PRIMPAGFebruary 2074 Moderate with Alternatives Tha report provides a summary of the inmstments in the accounts. listed above with their apixotimate values, subject to the qualifications below, for informational purposes only and should not be relied upon as the basis of an investment or ktuklatizn decision_ These accounts. which may have offering ownership, ate grouped together at the irotruction and consent of the affected owners. Any owner wishing to withdraw that consent should adrise us inmediately. Al information presented is subject to change at any time, is provided only as of the date indicated, and has been rounded for converience. UBS Financial Services Inc. account statements and official tar documents are the on/yoffeial record of your UBS Financial Services a:counts'. and are not replaced, amended. or superseded by any of the rilormation presented al these repots Values for investments held in your LBS financial Services accounel are taken front the exeunt statement for the designated date UBS Financial Services Inc does not provide tax or legal advice You should consult vets your attorney or fax Sam regarding your personal circumstances. Past performance is no guarantee of future returns CONFIDENTIAL UBSTERRAMAR00000198 EFTA00235927  Ghislaine Maxwell *UBS An« Allocation Workshcd <uf 011 UW Propos"' Current Propose.1 Perilourilon 1%) (%) Antount Amount %SUM US 0 4915Y AI ~0~0 GrOsCh (944.) 046646004 146% 00% 2.045.9t4 S ‘204i,y1.5 trx6ø4~4 052167006 3.7% 00% 5.75446 S (525.446) C49n 4 ECR40, 01C '0 V4993.56% 02% 00% 21.992 S (219321 Se Onyknd Øl1 Sa+0 I 1/49935006 04% 00% 52.249 S (52.243) ~to C..tOstWrastruct .1/ V49935056 01% 00% 24961 S (20.930 iberaseACP V40938104 03% 00% 35,914 S (36944 såerfark.~4 10014,00 UBS 00% 54% • 750000 250.030 Welpevroca čar Cas Craiala 0M4) U05 00% 54% 250.000 S 750.030 Rdnamtd7417 Anum1,65470 Ul* 00% 36% ¶.000 ¶,009 AtEr %OD UBS 00% 36% ¶.000 S 503,1200 LIS *abs~tati 193% 110% 1)8% 2.702536 2500003 S (202536) smetou &9+v fMmt'INgn0sv4n09AN V495Q0Z03 140% 00% 1,957.979 S (1.967,979) Sta t104p4ESIFC1 V405575COn 02% 00% 23.396 • S (23395) 14.1~4240na3tta7 94.9505005 0)% 00% 41.131 • s (41.1323 044~ nwn4ni.n.f UBS 00% 71% • 1.000.030 S 1..M.103 UBS 00% 18% • 250,0:0 250£40 UBS 00% 18% 2501303 S 293.000 .1%naratimedfaudir duadoW 145% 13574 IQ" 2.032.Y.17 1:505.0:0 čs.3.4500 tquity SubtotAl 334% 34.5% MS% S 4735,043 S 450201303 S C235.04.1) F KED iNCOME MurvtipY hsecl Incorns 057167%6 15% 00% 215.376 • S 015.370 UBS 00% 122% 1715,376 S 1 715376 Atunicalf tatiasaame S.Motal 1.5% 165% 11.3% 215.376 1,115,376 rfr rAcCO "«.. Tank% SIS I540 Income And dno« tna~ IP/40185631:02 04% 04% 56421 56421 S Tane Deptreas 05216/06 2.2% 0.0% 315.070 S 015.070) trs:~ Corpaar: 052167006 2.2% 0.Ø 310.920 (310.5000 E40:0 VaNtt Fittawv)R.C.- 94.69350:4 06% 00% 84.270 S (84270) ~na Ctectt Susers V4990.5006 02% 0.0% 31.123 S (31.123) Osten& Szean~epec8 V495.35006 04% 00% 571382 (57.881) 54/etiouran mu V49635005 05% 00% 75479 S 175.6750 /14boď/104 Y441 V400!5:05 03% 00% *873 S 08,873) eliet)C4Ccrberte V499360:6 01% 00% 30.939 S 130.9391 Ja4 Aktu Sectoď :ran,- V499350:6 04% 00% 49331 S 149331) ‘002.6.0lh Sen Fkotry v49.935006 04% 00% 56914 S (58.914) 74.414 Fkw.r.9 Part. V45915005 04% 00% 55.450 S (55.450) 67470044,10/1~8C61 V45435006 04% 00% 59~ S 09.869) GS54bRestc,Kcere V4~001) 07% 00% 92.480 S (92433) ge,4C01.mccnne441 V40938000 1.1% 00% 158.679 S (158679) PrueltdanalAMOArteRet4n0007 val») 07% 00% 94.667 S (94057) E.KOn Vanrenaht,n2Rie V40938000 04% 00% 50213 S 00.313) alAirlt. ecteeår V466138000 07% 00% 99.507 S M.507) FE/C6.148.2y AtoterteRaůnBr4 V4922800) I.1% 00% 153.465 S 053.855/ Relenerls 052167006 43% 00% 607.516 (27.5161 Colinč.e0Sineas V4503,•(06 01% 00% 20478 S (244783 D.:~e Ittarrenťm V49935CCO 07% 07% 97419 97,819 S 004)69, kea.eknum V493=6 1.0,% I.1% 1 x 730 152.181 17,451 AŘ St04e9c "Vn! V499.350:6 03% 03% 35.869 35452 fnd Strieer Wayne V4950FCCO 1.1% 51% 150.739 714.141 $ $63.402 /%544•00' Snad? . beome UBS 00% 54% 750.033 S 750,030 5,mp0.5ey es...S1' Gopnntes UBS 00% 3.6% 930000 S ¶,000 a arald nin:?-4, 77i ddr, USS 00% 36% ¶.000 S 500,000 UBS 00% 1.8% 150.003 S 250,0» taaatda ttf f a ael~met Subreta/ 204% 4" 11 6% 1.911.453 3056421 134, Istenrabonal %Red Incone 10.51;trandru ndand. V40%50:6 03% 00h 38.0% S 080)9 ‚4210Einperg ~re/ 94.9934CO3 04% 0.0% 56.933 66.933) 5.,...,..ery Gr.w8.-...! UBS 00% 36% ¶00.003 S ¶,000 Inarntatioadaanhatanie Sabtotal 07% 3C!% 3c% *1•v39 ¶.000 S 435$1 Frectinťome Subtotal 233% 373% 374% S 3.232371 S 5.272397 S 2.040.019 AntlItRATIVI NVISTLIt147$ Mutuj Fund Uciutd MNrrubves Non an, hoaml UBS 00% 54% S 750050 S 750,1200 UBS 00% 54% S 750000 S 7500» NomOnwtiona/SarbfeW 006 101% S 1.500000 S 1.501540 Dělt~ Co"-ws, (.5; b.,(Iff V4-070ČCC6 02% 0.04 S 31.576 S • S (11,57Q ..tede, e1/ UBS 00% 36% S • S ¶.000 S ¶.000 19.K.1eak &stu, ti &ne, UBS 00% 36% S S ¶.000 S ¶.000 ďarectianat~teta! 0 2% 1 1% 5 31n<. S 1 000 000 5 9`6.4)4 Zn:~Altem...ves Subreta! Prive% Státy/ Pekel* Real %%á s $ />Natt kuka/Mni • RFMblefr Sobtotd s Conaďtat n atateb 052167006 7777 s tanecir(na /HadAssebSubtotal 02% d1,451 lAttemative bwestnttvlb ~teta/ 0.4% U0% 17.8% S MA38 2$00P00 2,044,362 OSN L ICOJIVAIDIT$ 062167006 199% O 0% S 2.289.951 S (2.783.61) 2916490721 223% 114% S 3.122.458 S 2.161,061 (561387) V46605» 03% 03% S 36933 36993 V4983eCCO 0!% 03% S 47,,s1.0 S 47 Ouib I tizuk•Innla Subbtel , _ . .e 5 2245404 (3.7513.43) L OWC.ash reptanlent. Subtotal 428% OD% 16.0% S 5,997,102 S U1S,414 (3.7131J10 I4ťax Tni 'UM PWMPA4 FrBrvatVlON Aloavate atd, Alternativ« 774 «ved 4«,..41. a ‚Jíra,» dd II -,40-dr0 r arťannial lardi aldaůd •nl aIddna na‘nt 44..‘u4tN, Tn ' 4L4i?dani% to' glIonna~ pipcw, Cent 4r0 ‚Soli rol te s44‘1.4.:n tle ran ot ataanwal et Saalanen aaceace 1nse s<o-nts, rr9, ta.t Rc.r..0 cinn~p. are Srosee6 toperber Iheue./nrceenoncicreenl 01 are 41Iette0o4ne5 Ani~ wehn2 to erel•Srew har cereen1shcodaboe W rnreciatel9 Al InloreMon cresereel Sut*dt ct9r9eatny 14e. 6 (07rded C'elf 35« 11.44.054$~0.464 1346 febr ~6.1 coneinence 1.185 1~4 SenKe111( xce...res stateřnolts .r4 011.031 ta. Occueents re re ony 4:41x..4 mord of rxr ut35 F.na-4.1 Sem«, sccunt(s) ano ae rot re$xel. afrefole% Cdf~ed bys, IIK 4ťoentnencrisent610 Rex repcels 1,41,e5 for enessilens telchn your 0135finenced Ser«.41 ac(svels) are Lodi) true. Ina 4«ositststerreee for he deůralea mu. 065 1~4 inaltet Ind Cbetned woode taes10211a~ YOuStadd<Cfradl'enth,tur ABOrtes Ce ta. 45duar reg4,dn) pl ØY OrCuunlirdn Pat zerberrunce a no ~zda «1~ returns CONFIDENTIAL UBSTERRAMAR00000199 EFTA00235928  Wealth Ghislaine Maxwell UBS Management di Hypothetical Portfolio Analytics February-14 Current Allocation Proposed Allocation Taxable Fixed International International Income Fixed Income Fixed Income 21% 1% 4% Liquid Alternative Taxable Fixed .. InveLtme% nts Income 21% Municipal Fixed Income 2% Can & International Equivalents Equity 43% 14% Municipal Fixed Cash & Income Equivalents 12% 16% International US Equity Equity US Equity 19% 11% 18% Forward-Looking Data (Next 10 Years) Forward-Looking Data (Next 10 Years) Estimated Risk 6 48% Estimated Risk 6 85% Estimated Return 4.52% Estimated Return 4 99% Expected Sharpe Ratio 0.3 Estimated Sharpe Ratio 04 Historical Data (Previous 10 Years) Historical Data (Previous 10 Years) Annualized Risk 5.90% Annualized Risk 6.36% Annualized Return 4.34% Annualized Return 5.47% Historical Sharpe Ratio 0.5 Historical Sharpe Ratio 0.6 Best Rolling Year 21.77% Best Rolling Year 24.64% Worst Rolling Year -1990% Worst Rolling Year -18.74% Benchmark Data (Previous 10 Years) S&P 500 6.80% RISK FREE RATE (10-Year Treasury Bill) 2.67% BC AGGREGATE 4.60% GLOBAL HEDGE FUND INDEX (HFRXGL) 0.88% Previous 10 year data based on period from: 1131/2004-1/3112014 The information provided to you is for informational purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy any securities. The asset classes and asset allocation shown are illustrative and may reflect your current allocation, one of the UBS Strategic Allocation Models or a customized asset allocation model. Results shown are hypothetical, are provided for illustrative purposes only and do not include the impact of transaction cost, taxes and inflation. If included, the results shown would be lower. The results are based on UBS simulation over the specified time horizon. Actual results may vary dependng on the specific composition of the investor's portfolio. Actual results may also vary dependng on when the portfolio is implemented and may be affected by changng market conditions. Past performance or historic result provide no guarantee of future returns. Forward4coking estimated results and probabilistic analysis should not be construed as a guarantee and are provided for illustrative purposes only. CONFIDENTIAL UBSTERRAMAR00000200 EFTA00235929  Disclaimers *UBS Wealth Management This analysis has been provided to you by UBS AG and/or affiliates CUBS"), for informational purposes only and should not be used in substitution for the exercise of independent judgement. This material contains data derived as a result of back-testing of data and is provided by UBS in good faith using its standard methodology for information of this kind. That methodology relies on proprietary models, empirical data, assumptions and such other information that we believe to be accurate and reasonable. The current data that UBS selected for preparation of this material may be substantially different if the date is selected from a different time period and this may have substantial impact on the back-testing results. This information is provided to you for information purpose only and we make no representation as to the accuracy, completeness or appropriateness of such methodology and accept no liability for your use of the information. Specifically, there is no assurance that other banks or brokers would derive the same results for the back-test period or that such results would have been achieved in practice. Potential investors should not rely on this material for the purpose of understanding the probability that they may lose their initial investment in investing in the subject product. Prospective Investors should also note that back-testing results may project unrealistic expectation on the performance of the subject product. Past performance is not necessarily indicative of future results. This material does not guarantee the performance of the subject product in all circumstances and UBS shall not be responsible for any investment loss suffered by the investors in investing in the subject product in this respect. The back-testing results has not considered the risks involved in investing in the subject product, including but not limited to the credit risk of the issuer of the subject product. These risks may lead to the loss of investors initial investment in the subject product and investors should read the risks stated in the offering documents of the subject product before investing in the subject product. Under no circumstances shall have any liability for a) any loss, damage or other injury in whole or in part caused by, resulting from or relating to, any error (negligent or otherwise) of UBS in connection with the compilation, methodology, interpretation. communication, publication or delivery of this analysis, orb) any direct, indirect, special, consequential, incidental or compensatory damages whatsoever (including, without limitation, lost profits), in either case caused by reliance upon or otherwise resulting from or relating to the use of (including the inability to use) this analysis. This analysis is confidential. You may not pass on this analysis to any third party without the express permission of UBS. C UBS [2012] This material has been prepared by UBS AG or an affiliate thereof CUBS"). This material is for distribution only under such circumstances as may be permitted by applicable law. It has no regard to the specific investment objectives. financial situation or particular needs of any specific recipient. It is published solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. No representation or warranty, either express or implied, is provided in relation to the accuracy. completeness or reliability of the information contained herein except with respect to information concerning UBS AG its subsidiaries and affiliates, nor is it intended to be a complete statement or summary of the securities markets or developments referred to in this material. It should not be regarded by recipients as a substitute for the exercise of their own judgment. Any opinions expressed in this material are subject to change without notice and may differ or be contrary to opinions expressed by other business areas or groups of UBS as a result of using different assumptions and criteria. UBS is under no obligation to update or keep current the information contained herein. UBS. its directors, officers and employees' or clients may have or have had interest or long or short positions in the securities or other financial instruments referred to herein and may at any time make purchases andlor sales in them as principal or agent. UBS may act or have acted as market-maker in the securities or other financial instruments discussed in this material. Furthermore, UBS may have or have had a relationship with or may provide or has provided investment banking, capital markets andlor other financial services to the relevant companies. Neither UBS nor any of its affiliates, nor any of UBS' or any of its affiliates, directors, employees or agents accepts any liability for any loss or damage arising out of the use of all or any part of this material. Additional information may be made available upon request. In the U.S., securities underwriting, trading and brokerage activities and WA advisory activities are conducted by UBS Securities LLC. a wholly owned subsidiary of UBS AG that is a registered broker-dealer and a member of FINRA, the NYSE, and other principal exchanges and SIPC. UBS specifically prohibits the redistribution or reproduction of this material in whole or in part without the written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect. C UBS 2011. All rights reserved. This material has been prepared by UBS AG or an affiliate CUBS"). This material is for distribution only as permitted by law. It is not prepared for the needs of any specific recipient. It is published solely for information and is not a solicitation or offer to buy or sell any securities or related financial instruments (Instruments'). UBS makes no representation or warranty, either express or implied, on the completeness or reliability of the information contained in this document (Information) except that concerning UBS AG and its affiliates. The Information should not be regarded by recipients as a substitute for using their own judgment. Any opinions expressed in this material may change without notice and may be contrary to opinions expressed by other business areas of UBS as a result of using different assumptions or criteria. ues is under no obligation to update the Information. UBS, its officers, employees or clients may have or have had an interest in the Instruments and may at any time transact in them. UBS may have or have had a relationship with entities referred to in the Information. Neither UBS nor any of its affiliates. or their officers or employees, accepts any liability for any loss arising from use of the Information. This presentation is not a basis for entering into a transaction. Any transaction between you and UBS will be subject to the detailed provisions of the term sheet. confirmation or electronic matching systems relating to that transaction. Clients wishing to effect transactions should contact their local sales representative. For Instruments admitted to trading on an EU regulated market: UBS AG, its affiliates or subsidiaries may act as a market maker or liquidity provider (in accordance with the interpretation of these terms in the UK) in the Instrument. CONFIDENTIAL UBSTERRAMAR00000201 EFTA00235930